Literature DB >> 7307000

Dose response studies of carcinogenesis in rats by nitrosodiethylamine.

W Lijinsky, M D Reuber, C W Riggs.   

Abstract

A dose-response study was conducted in Fischer rats with nitrosodiethylamine, which was administered in regulated amounts as a solution in drinking water. Groups of 20 female rats each received a different treatment, one group consisted of 12 animals; one of the groups was untreated. The concentrations of the solutions fed ranged from 113 to 0.45 mg/liter at six successive concentrations differing from a factor of 2.5. The treatment times were 17 weeks at the highest concentration; 22 weeks with 45 mg/liter; and 30 weeks with 18, 7, 2.8, 1.1 and 0.45 mg/liter. The two lowest dose levels were also given for 60 weeks, and the 0.45-mg/liter dose was given for 104 weeks. Animals were allowed to die naturally with tumors, and the time to death with tumors was an index of the potency of treatment. In the top four treatment groups, the potency measured in this way was proportional to the total dose of carcinogen administered. At all other doses, survival time was much less dependent on the dose administered, whether or not tumors were induced by the treatment. The principal tumors found were in the upper gastrointestinal tract, mainly the esophagus, at all doses. In the two highest dose groups, there was a high incidence of liver tumors also. There were few liver tumors in the lower dose groups, but there was a dose-related incidence of tumors of the upper gastrointestinal tract. It was remarkable that a nitrosodiethylamine concentration of 0.45 mg/liter (0.45 ppm) administered for 104 weeks induced tumors of the upper gastrointestinal tract in 70% of the treated rats.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7307000

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease.

Authors:  Ming Tong; Alexander Neusner; Lisa Longato; Margot Lawton; Jack R Wands; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

2.  Dose-response study of urinary bladder carcinogenesis in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  N Ito; T Shirai; S Fukushima; M Hirose
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 3.  Structure-activity relations in carcinogenesis by N-nitroso compounds.

Authors:  W Lijinsky
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Cell-permeable esters of diazeniumdiolate-based nitric oxide prodrugs.

Authors:  Harinath Chakrapani; Anna E Maciag; Michael L Citro; Larry K Keefer; Joseph E Saavedra
Journal:  Org Lett       Date:  2008-10-29       Impact factor: 6.005

Review 5.  Deuterium isotope effects in carcinogenesis by N-nitroso compounds.

Authors:  W Lijinsky
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

6.  Carcinogenesis in F-344 rats by nitrosobis(2-oxopropyl)amine and related compounds administered in drinking water.

Authors:  W Lijinsky; J E Saavedra; M D Reuber
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

7.  Species differences in nitrosamine carcinogenesis.

Authors:  W Lijinsky
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 8.  Epidemilogical trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis.

Authors:  Suzanne M de la Monte; Alexander Neusner; Jennifer Chu; Margot Lawton
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

9.  Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.

Authors:  Ming Tong; Lisa Longato; Suzanne M de la Monte
Journal:  BMC Endocr Disord       Date:  2010-03-19       Impact factor: 2.763

10.  Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.

Authors:  Suzanne M de la Monte; Ming Tong; Margot Lawton; Lisa Longato
Journal:  Mol Neurodegener       Date:  2009-12-24       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.